Inhibitory Activities of Gatifloxacin (AM-1155), a Newly Developed Fluoroquinolone, against Bacterial and Mammalian Type II Topoisomerases

We determined the inhibitory activities of gatifloxacin against Staphylococcus aureus topoisomerase IV, Escherichia coli DNA gyrase, and HeLa cell topoisomerase II and compared them with those of several quinolones. The inhibitory activities of quinolones against these type II topoisomerases signifi...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Takei, Masaya, Fukuda, Hideyuki, Yasue, Tokutaro, Hosaka, Masaki, Oomori, Yasuo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Mechanisms of Action: Physiological Effects
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105918/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9756776/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.10.2678
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!